sinoderm n 0.25 mg/1 g+ 3.3 mg/1 g mast
galenika d.o.o. - fluocinolon acetonid, neomicin - mast - 0.25 mg/1 g+ 3.3 mg/1 g - 1 g masti sadrži: 0,25 mg fluocinolon acetonida i 3,30 mg neomicina (u obliku neomicinsulfata)
methylergometrin 0.25 mg/1 ml oralne kapi, rastvor
hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - Метилэргометрин - oralne kapi, rastvor - 0.25 mg/1 ml - 1 ml oralnih kapi, rastvora sadrži: 0,25 mg metilergometrinmaleata
forthyron flavoured, 200 mikrograma
eurovet animal health b.v., handelsweg 25, 5531 ae bladel, nizozemska - levotiroksinnatrij - tableta - sintetski hormoni štitne žlijezde - pasa
forthyron flavoured, 400 mikrograma
eurovet animal health b.v., handelsweg 25, 5531 ae bladel, nizozemska - levotiroksinnatrij - tableta - sintetski hormoni štitne žlijezde - pasa
forthyron flavoured, 600 mikrograma
eurovet animal health b.v., handelsweg 25, 5531 ae bladel, nizozemska - levotiroksinnatrij - tableta - sintetski hormoni štitne žlijezde - pasa
forthyron flavoured, 800 mikrograma
eurovet animal health b.v., handelsweg 25, 5531 ae bladel, nizozemska - levotiroksinnatrij - tableta - sintetski hormoni štitne žlijezde - pasa
olumiant
eli lilly nederland b.v. - baricitinib - artritis, reumatoidni - imunosupresivi - rheumatoid arthritisbaricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). olumiant se može koristiti kao monoterapija ili u kombinaciji s metotreksatom. atopic dermatitisolumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. alopecia areatabaricitinib is indicated for the treatment of severe alopecia areata in adult patients (see section 5. juvenile idiopathic arthritisbaricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic dmards:- polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [rf+] or negative [rf-], extended oligoarticular),- enthesitis related arthritis, and- juvenile psoriatic arthritis. baricitinib may be used as monotherapy or in combination with methotrexate.
opgenra
olympus biotech international limited - eptotermin alfa - spondilolisteze - lijekovi za liječenje bolesti kostiju - opgenra je indicirana za posterolateralnu lumbalnu spinalnu fuzije u odraslih bolesnika s spondilolistezijom u kojima autograft nije uspio ili je kontraindiciran.
acipirin 4 g/0,5 g prašak za otopinu za infuziju
pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - piperacilinnatrij tazobaktamnatrij - prašak za otopinu za infuziju - 4,0 g + 0,5 g/bočica - urbroj: jedna bočica sadrži 4,0 g piperacilina u obliku piperacilinnatrija i 0,5 g tazobaktama u obliku tazobaktamnatrija
piperacilin/tazobactam fresenius kabi 2 g/0,25 g prašak za otopinu za infuziju
fresenius kabi d.o.o., radnička cesta 37a, zagreb, hrvatska - piperacilinnatrij tazobaktamnatrij - prašak za otopinu za infuziju - 2 g/0,25 g - urbroj: svaka bočica sadrži 2 g piperacilina u obliku piperacilinnatrija i 0,25 g tazobaktama u obliku tazobaktamnatrija